[Potential use of exogenous phosphocreatine (neoton) in the combined therapy of cancer complicated with cardiovascular diseases].
Perepech
N B
NB
D000970:Antineoplastic Agents / Q000009:adverse effects*; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000139:chemically induced / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D009369:Neoplasms / Q000150:complications* / Q000188:drug therapy; D010725:Phosphocreatine / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D002316:Cardiotonic Agents; D010725:Phosphocreatine